EBV-encoded LMP1 upregulates igκ 3′enhancer activity and Igκ expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling

Medicine & Life Sciences

• Nasopharyngeal Neoplasms 100%
• Human Herpesvirus 4 70%
• Membrane Proteins 59%
• Up-Regulation 51%
• Nasopharyngeal Carcinoma 48%
• 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 25%
• Proto-Oncogene Protein c-ets-1 24%
• Light 20%
• Phosphorylation 19%
• MAP Kinase Signaling System 15%
• Immunoglobulins 12%
• Small Interfering RNA 11%
• Immunoglobulin kappa-Chains 11%
• Activating Transcription Factors 10%
• Epithelial Cells 10%
• Immunoglobulin Light Chains 9%
• Gene Expression 8%
• Luciferases 6%
• Gels 5%
• Binding Sites 5%
• Proteins 5%
• Viruses 4%
• Neoplasms 4%
• Cell Line 4%
• Mutation 3%
• In Vitro Techniques 3%

Agriculture & Biology

• membrane proteins 65%
• neoplasm cells 65%
• carcinoma 45%
• phosphorylation 24%
• transcription factors 16%
• small interfering RNA 16%
• immunoglobulins 13%
• cells 13%
• epithelial cells 12%
• assays 11%
• gene expression 8%
• luciferase 7%
• binding sites 6%
• cell lines 5%
• mutation 4%
• gels 4%
• proteins 4%
• viruses 4%
• extracts 3%
• dosage 3%

Chemical Compounds

• Enhancer 56%
• Protein 29%
• Small Interfering RNA 16%
• Mutation 5%
• Binding Site 4%
• Gel 3%